OKYO Pharma Limited (NASDAQ:OKYO) has a beta value of -0.04 and has seen 65636.0 shares traded in the last trading session. The company, currently valued at $40.61M, closed the last trade at $1.20 per share which meant it lost -$0.13 on the day or -9.77% during that session. The OKYO stock price is -150.0% off its 52-week high price of $3.00 and 32.5% above the 52-week low of $0.81. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.9 million shares traded. The 3-month trading volume is 180.90K shares.
The consensus among analysts is that OKYO Pharma Limited (OKYO) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
OKYO Pharma Limited (NASDAQ:OKYO) trade information
Sporting -9.77% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the OKYO stock price touched $1.20 or saw a rise of 11.11%. Year-to-date, OKYO Pharma Limited shares have moved -32.20%, while the 5-day performance has seen it change 15.38%. Over the past 30 days, the shares of OKYO Pharma Limited (NASDAQ:OKYO) have changed 20.60%. Short interest in the company has seen 65931.0 shares shorted with days to cover at 0.78.
OKYO Pharma Limited (OKYO) estimates and forecasts
Figures show that OKYO Pharma Limited shares have outperformed across the wider relevant industry. The company’s shares have lost -17.81% over the past 6 months, with this year growth rate of 33.33%, compared to 18.00% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -126.59% over the past 5 years.
OKYO Dividends
OKYO Pharma Limited is expected to release its next earnings report in October this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
